Biopharmaceutical multinational AbbVie said it will create 70 new jobs at its facility in Cork as part of a €60 million investment. The expansion of its site at Carrigtwohill will allow the operation there to support the company’s aesthetics business, it said. Construction will start next year, with the expansion expected to be completed by 2025.
“The expansion and associated cutting-edge technologies will help us to further develop our employees and attract new skilled talent,” AbbVie Cork site director Malcolm Garde said. This is “a fantastic opportunity for the Cork site”.
The 70 new roles will be spread across various areas including sterile manufacturing, quality control, and engineering, and are supported by IDA Ireland. The Carrigtwohill site employs about 150 people at present.
As well as the investment AbbVie is also starting a three-year strategic training programme at the Carrigtwohill facility, the IDA said. The initiative is supported by the Government through the IDA, and will enhance and develop key workforce skills to support incoming new technologies, it added.
Parties’ general election manifestos struggle to make the figures add up
On his return to Web Summit, the often outspoken chief executive Paddy Cosgrave is now an epitome of caution
Surviving a shake-up: is restructuring ever good for staff?
The Irish Times Business Person of the Month: Dalton Philips, Greencore
“This investment will reduce the carbon footprint at the Cork site and is setting a good example for the broader sector,” said Minister for Enterprise Leo Varadkar.
The move brings AbbVie total investment in the site since 2013 to €177 million. The Chicago-based group can trace its heritage in Ireland back to 1974.
